All companies
Visit website
MEDILOQ
OperatingMediloq, Inc.
Retail · Founded 2021
Pioneered durable, ruggedized, child-safe containers for the b2c outdoor recreational market
Post-money valuation ⓘ
$6.0M
As of Feb 2023 · from Mediloq Common Stock 2 · pre-money + amount raised, not a traded price
Total raised
$57,061
Across 2 rounds since 2021
Latest share price
$2.37
Mediloq Common Stock 2 offering price
Financials
FY2019–FY2023 · from SEC filings · hover any figure for its source$54K
−$39K
2019
$39K
−$46K
2020
$24K
−$23K
2021
$26K
−$19K
2022
$14K
−$40K
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019
FY2020
FY2021
FY2022
FY2023
Income statement
Revenue
$54,330
$39,091
$23,733
$26,282
$13,568
Cost of goods sold
$63,831
$52,211
$6,906
$9,437
$7,296
Gross margin
-17%
-34%
71%
64%
46%
Net income
-$39,237
-$45,784
-$22,875
-$19,099
-$40,153
Taxes paid
$0
$0
$0
$0
$0
Balance sheet
Cash
$1,154
$2,981
$791
$11,489
$1,337
Accounts receivable
$0
$0
$0
$0
$0
Total assets
$52,759
$55,363
$9,474
$20,169
$10,017
Short-term debt
$57,409
$58,724
$73,970
$79,174
$91,629
Long-term debt
$79,542
$126,615
$4,400
$4,378
$4,246
Total liabilities
$136,951
$185,339
$78,370
$83,552
$95,875
Other
Headcount
—
0
1
0
0
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$6.0M
post-money
Mediloq Common Stock 2
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $20.3K / $581.2KInvestors 17Post-money $6M
Raised $36.8K / $1.1M
Reg CF annual-report compliance
Not requiredFiled Form C-TR (terminated reporting)
Filed 2 of 5 annual reports (FY2021–FY2025)
17 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 10 filings on EDGARSource: ManualCIK 0001858449Share price $2.37
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.